文献速递胰腺与胆道疾病消化内镜

无症状胆总管扩张患者EUS诊断率的系统评价与荟萃分析

Evaluation of diagnostic yield of EUS among patients with asymptomatic common bile duct dilation: systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2021-07-07

该系统评价与荟萃分析纳入8项研究共224例无症状胆总管扩张患者,评估EUS的诊断率。结论认为EUS可发现结石和恶性肿瘤但比率低,需成本效果分析指导决策。

要点

  • 无症状胆总管扩张患者EUS检出任何病变的累积诊断率为11.2%。
  • 良性病因检出率9.2%,其中胆总管结石为3.4%。

核心结论

  • EUS在无症状胆总管扩张患者中可发现胆总管结石和恶性肿瘤,但检出率低。
  • 需开展成本效果分析以进一步指导该领域的临床决策。

研究设计与样本

  • 系统评价与荟萃分析,检索Cochrane Library、Ovid Embase、Google Scholar、Ovid Medline、PubMed、Scopus和Web of Science Core Collection。
  • 最终纳入8项研究,共224例无症状胆总管扩张患者。
  • 采用逆方差法和随机效应模型对比例进行荟萃分析,计算累积EUS诊断率。

主要发现

  • EUS对任何病变的累积诊断率为11.2%(95%CI 3.6%-21.6%)。
  • EUS对良性病因的诊断率为9.2%(95%CI 1.1%-21.9%),其中胆总管结石占3.4%(95%CI 0%-11.2%)。

临床怎么用

  • 对于无症状胆总管扩张患者,EUS可检出低比例的胆总管结石和恶性肿瘤,临床决策需结合成本效果分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Common bile duct (CBD) dilation is a frequent indication for EUS. Among asymptomatic individuals, biliary dilation may not be clinically significant; however, EUS is often relied on for the exclusion of benign and malignant pathology that might require further intervention. The yield of EUS evaluation for this indication is not well characterized and has significant implications for health resource utilization because asymptomatic biliary dilation is prevalent. Through this systematic review, we sought to appraise the yield of EUS evaluation of asymptomatic patients with radiologic evidence of isolated CBD dilation. METHODS: A protocolled search (PROSPERO: CRD42020193428) extracted original studies from the Cochrane Library, Ovid Embase, Google Scholar, Ovid Medline, PubMed, Scopus, and Web of Science Core Collection that described diagnostic yield of EUS among asymptomatic patients with biliary dilation. Cumulative EUS diagnostic yield was calculated through meta-analysis of proportions using inverse variance methods and a random-effects model. RESULTS: Of 2616 studies, 8 delineated the EUS yield among 224 asymptomatic patients. The cumulative yield of EUS for any pathology was 11.2% (95% confidence interval [CI], 3.6%- 21.6%). The EUS yield for benign etiologies was 9.2% (95% CI, 1.1%-21.9%), of which choledocholithiasis comprised 3.4% (95% CI, 0%-11.2%) and malignant etiologies .5% (95% CI, 0%-3.4%) of cases. CONCLUSIONS: EUS in patients with asymptomatic CBD dilation does yield findings of choledocholithiasis and malignancy, albeit at low rates. A cost-effectiveness analysis is warranted to further guide clinical decision-making in this area.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Chhoda A, Dawod S, Grimshaw A, et al. Evaluation of diagnostic yield of EUS among patients with asymptomatic common bile duct dilation: systematic review and meta-analysis. Gastrointest Endosc. 2021. PMID: 34245751. doi:10.1016/j.gie.2021.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。